Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Gail Hecht MD
Gail Hecht MD Editor-in-Chief
Scott Cotler MD
Scott J. Cotler MD Associate Editor
Steven Edmundowicz MD, MASGE
Steven A. Edmundowicz MD, MASGE Associate Editor
See All Experts
featured
Published in Gastroenterology

Expert Opinion / Commentary · August 05, 2015

Treating HCV Isn't as Easy as It Used to Be

Juliana Chan PharmD
Rima Mohammad PharmD, BCPS

 

 Save  Recommend
 Share

Additional Info

  1. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Updated September 25, 2014. Accessed July 26, 2015.
  2. Burger D, Back D, Buggisch P, et al. Clinical management of drug-drug interactions in HCV therapy: challenges and solutions. J Hepatol. 2013;58(4):792-800. http://www.journal-of-hepatology.eu/article/S0168-8278%2812%2900828-8/abstract
  3. Menon RM, Badri PS, Wang T, et al. Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir. J Hepatol. 2015;63(1):20-29. http://www.journal-of-hepatology.eu/article/S0168-8278%2815%2900057-4/abstract

Further Reading

Most Read This Week

Recently Updated